In our recent study, arginase inhibition combined with an anti-PD-1 antibody effectively reduced glioma growth in mice [35], prompting us to hypothesize that 7aaRGD-driven phenotype switch of GAMs may also contribute to an improved response to ICIs and potentially to other immunotherapies. The gene discussed is PDCD1; the disease is glioma.